Brind.

Indivior's inclusion in a Russell index aligns with its U.S. business profile.

1 report, 0 independent Updated Jun 30

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Indivior FTSE Russell

Keep exploring

The entities involved

Indivior
specialty pharmaceuticals business headquartered in Richmond, Virginia
- Indivior and Addex Therapeutics regained full global rights to GABAB PAM assets.Mon 06:10
- Addex Therapeutics and Indivior are partnering on a drug candidate.Fri 07:58
FTSE Russell
British provider of stock market indices
- Market cap valuation of SpaceX is nearing parity with Amazon.com, while MSCI and FTSE Russell are considering adding SpaceX to their indices.Mon 03:37
- Meta's IPO was mentioned in relation to Nasdaq, and SpaceX debuted on the Nasdaq stock exchange.Sun 23:35

Coverage

Newest first; wire copies grouped

Jun 30Unknown outlet